Show source-provided references
2. Maraghelli, D., Pietragalla, M., Calistri, L., Barbato, L., Locatello, L.G., Orlandi, M., Landini, N., Casto, A.L., and Nardi, C. (2022). Techniques, Tricks, and Stratagems of Oral Cavity Computed Tomography and Magnetic Resonance Imaging. Appl. Sci., 12.
10.3390/app12031473 ↗3. CT assessment of tumor heterogeneity and the potential for the prediction of human papillomavirus status in oropharyngeal squamous cell carcinoma
10.1007/s11547-019-01028-6 ↗6. Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: A 9-year, 337-patient, multi-institutional experience
10.1093/annonc/mdh308 ↗7. MRI with DWI for the Detection of Posttreatment Head and Neck Squamous Cell Carcinoma: Why Morphologic MRI Criteria Matter
10.3174/ajnr.A5548 ↗9. Evaluation of Head and Neck Squamous Cell Carcinoma After Treatment
10. A practical overview of CT and MRI features of developmental, inflammatory, and neoplastic lesions of the sphenoid body and clivus
10.1007/s00234-022-02986-x ↗11. Multiparametric functional MRI and 18F-FDG-PET for survival prediction in patients with head and neck squamous cell carcinoma treated with (chemo)radiation
10.1007/s00330-020-07163-3 ↗12. Dynamic Contrast-Enhanced MR Imaging in Head and Neck Cancer: Techniques and Clinical Applications
10.3174/ajnr.A4458 ↗15. Histogram analysis parameters identify multiple associations between DWI and DCE MRI in head and neck squamous cell carcinoma
10.1016/j.mri.2017.09.015 ↗16. Texture analysis in the characterization of parotid salivary gland lesions: A study on MR diffusion weighted imaging
10.1016/j.ejrad.2021.109529 ↗19. Principles and Applications of Diffusion-weighted Imaging in Cancer Detection, Staging, and Treatment Follow-up
10.1148/rg.316115515 ↗22. The role of diffusion-weighted and dynamic contrast enhancement perfusion-weighted imaging in the evaluation of salivary glands neoplasms
10.1007/s11547-020-01182-2 ↗23. Imaging biomarkers in the diagnosis of salivary gland tumors: The value of lesion/parenchyma ratio of perfusion-MR pharmacokinetic parameters
10.1007/s11547-021-01376-2 ↗26. The Predictive Value of Early Assessment After 1 Cycle of Induction Chemotherapy with 18F-FDG PET/CT and Diffusion-Weighted MRI for Response to Radical Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma
10.2967/jnumed.116.174433 ↗27. Value of Diffusion-Weighted and Perfusion-Weighted MR Imaging in Differentiation of Recurrent Tongue Carcinoma from Post-Treatment Changes
10.21608/mjcu.2020.118546 ↗28. The ability of post-chemoradiotherapy DWI ADCmean and 18F-FDG SUVmax to predict treatment outcomes in head and neck cancer: Impact of human papilloma virus oropharyngeal cancer status
10.1007/s00432-021-03662-y ↗29. Development of a Multiparametric Voxel-Based Magnetic Resonance Imaging Biomarker for Early Cancer Therapeutic Response Assessment
10.18383/j.tom.2015.00124 ↗30. Intravoxel incoherent motion diffusion-weighted MRI during chemoradiation therapy to characterize and monitor treatment response in human papillomavirus head and neck squamous cell carcinoma
10.1002/jmri.25523 ↗31. T2-Weighted MR Imaging Early after Chemoradiotherapy to Evaluate Treatment Response in Head and Neck Squamous Cell Carcinoma
10.3174/ajnr.A3378 ↗32. Head and Neck Squamous Cell Carcinoma: Diagnostic Performance of Diffusion-weighted MR Imaging for the Prediction of Treatment Response
10.1148/radiol.12120167 ↗33. Squamous cell carcinoma of the head and neck: Diffusion-weighted MR imaging for prediction and monitoring of treatment response
10.1007/s00330-010-1769-8 ↗34. Diffusion-Weighted Magnetic Resonance Imaging Early After Chemoradiotherapy to Monitor Treatment Response in Head-and-Neck Squamous Cell Carcinoma
10.1016/j.ijrobp.2011.02.044 ↗35. Brenet, E., Barbe, C., Hoeffel, C., Dubernard, X., Merol, J.-C., Fath, L., Servagi-Vernat, S., and Labrousse, M. (2020). Predictive Value of Early Post-Treatment Diffusion-Weighted MRI for Recurrence or Tumor Progression of Head and Neck Squamous Cell Carcinoma Treated with Chemo-Radiotherapy. Cancers, 12.
10.3390/cancers12051234 ↗36. Diffusion-Weighted Magnetic Resonance Imaging for Predicting and Detecting Early Response to Chemoradiation Therapy of Squamous Cell Carcinomas of the Head and Neck
10.1158/1078-0432.CCR-08-1287 ↗37. Diffusion Weighted Imaging in Predicting Progression Free Survival in Patients with Squamous Cell Carcinomas of the Head and Neck Treated with Induction Chemotherapy
10.1016/j.acra.2011.06.009 ↗38. Predictive Values of MRI and PET Derived Quantitative Parameters for Patterns of Failure in Both p16+ and p16– High Risk Head and Neck Cancer
10.3389/fonc.2019.01118 ↗39. Fractional Change in Apparent Diffusion Coefficient as an Imaging Biomarker for Predicting Treatment Response in Head and Neck Cancer Treated with Chemoradiotherapy
10.3174/ajnr.A3706 ↗40. The prediction of the treatment response of cervical nodes using intravoxel incoherent motion diffusion-weighted imaging
10.1016/j.ejrad.2017.05.002 ↗41. Intravoxel incoherent motion imaging kinetics during chemoradiotherapy for human papilloma-virus-associated squamous cell carcinoma of the oropharynx: Preliminary results form a prospective pilot study
10.1002/nbm.3412 ↗42. Diffusion-weighted MR imaging including bi-exponential fitting for the detection of recurrent or residual tumour after (chemo)radiotherapy for laryngeal and hypopharyngeal cancers
10.1007/s00330-012-2596-x ↗43. Diagnostic Accuracy of Follow-Up FDG PET or PET/CT in Patients With Head and Neck Cancer After Definitive Treatment: A Systematic Review and Meta-Analysis
10.2214/AJR.14.14166 ↗44. Diffusion-weighted and PET/MR Imaging after Radiation Therapy for Malignant Head and Neck Tumors
10.1148/rg.2015140029 ↗45. Van Der Hoorn, A., Van Laar, P.J., Holtman, G.A., and Westerlaan, H.E. (2017). Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with head and neck tumors, a systematic review and meta-analysis. PLoS ONE, 12.
10.1371/journal.pone.0177986 ↗47. Local recurrence of squamous cell carcinoma of the head and neck after radio(chemo)therapy: Diagnostic performance of FDG-PET/MRI with diffusion-weighted sequences
10.1007/s00330-017-4999-1 ↗48. Functional magnetic resonance imaging of head and neck cancer: Performance and potential
51. D’Urso, P., Farneti, A., Marucci, L., Marzi, S., Piludu, F., Vidiri, A., and Sanguineti, G. (2022). Predictors of Outcome after (Chemo)Radiotherapy for Node-Positive Oropharyngeal Cancer: The Role of Functional MRI. Cancers, 14.
10.3390/cancers14102477 ↗52. Bicci, E., Nardi, C., Calamandrei, L., Pietragalla, M., Cavigli, E., Mungai, F., Bonasera, L., and Miele, V. (2022). Role of Texture Analysis in Oropharyngeal Carcinoma: A Systematic Review of the Literature. Cancers, 14.
10.3390/cancers14102445 ↗